Efficient Tumor Accumulation, Penetration and Tumor Growth Inhibition Achieved by Polymer Therapeutics: The Effect of Polymer Architectures

被引:17
作者
Shen, Tong [1 ]
Xu, Xin [2 ]
Guo, Linyi [1 ]
Tang, Hao [1 ]
Diao, Tongxiang [2 ]
Gan, Zhihua [1 ]
Zhang, Guan [2 ]
Yu, Qingsong [1 ]
机构
[1] Beijing Univ Chem Technol, Coll Life Sci & Technol, Beijing Lab Biomed Mat, State Key Lab Organ Inorgan Composites, Beijing 100029, Peoples R China
[2] China Japan Friendship Hosp, Dept Urol, Beijing 100029, Peoples R China
基金
中国博士后科学基金;
关键词
N-(2-HYDROXYPROPYL)METHACRYLAMIDE COPOLYMER-DOXORUBICIN; MOLECULAR-WEIGHT; PHASE-I; DRUG-DELIVERY; BODY DISTRIBUTION; BLOCK-COPOLYMERS; SURFACE-CHARGE; MICELLES; BIODISTRIBUTION; ANTICANCER;
D O I
10.1021/acs.biomac.6b01533
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
To obtain high tumor-specific accumulation, strong tumor penetration and low off-target uptake, we developed a series of polymer therapeutics with different architectures, including random, block, and brush-like structure; based on the classic N-(2-hydroxypropyl) methacrylamide polymers. The influence of polymer architecture on biological properties such as cellular uptake, blood clearance, and biodistribution have been investigated. Besides small micelles whose sizes were determined by polymer architectures, large aggregates formed by micelle aggregation could also be observed. Although they had different architectures, the drug release rate, endocytic pathways and cellular uptake level of various conjugates have been proved to be identical. The polymer architecture of various conjugates lay great impact on the blood clearance, biodistribution and tumor growth inhibition. We assumed that the differences in in vivo biological properties were coordinately caused by the different size of the small aggregates and the formation and stability of large aggregates for different conjugates. Even though the reason was still unclear, the results inspired us that only by diblock conjugates with improved cellular uptake can we realize tumor specific accumulation, deep penetration, and efficient tumor inhibition.
引用
收藏
页码:217 / 230
页数:14
相关论文
共 52 条
[1]   Drug delivery systems: Entering the mainstream [J].
Allen, TM ;
Cullis, PR .
SCIENCE, 2004, 303 (5665) :1818-1822
[2]   PEGylation of HPMA-based block copolymers enhances tumor accumulation in vivo: A quantitative study using radiolabeling and positron emission tomography [J].
Allmeroth, Mareli ;
Moderegger, Dorothea ;
Guendel, Daniel ;
Buchholz, Hans-Georg ;
Mohr, Nicole ;
Koynov, Kaloian ;
Roesch, Frank ;
Thews, Oliver ;
Zentel, Rudolf .
JOURNAL OF CONTROLLED RELEASE, 2013, 172 (01) :77-85
[3]   Modifying the Body Distribution of HPMA-Based Copolymers by Molecular Weight and Aggregate Formation [J].
Allmeroth, Mareli ;
Moderegger, Dorothea ;
Biesalski, Barbara ;
Koynov, Kaloian ;
Roesch, Frank ;
Thews, Oliver ;
Zentel, Rudolf .
BIOMACROMOLECULES, 2011, 12 (07) :2841-2849
[4]   Dynamic imaging of PEGylated indocyanine green (ICG) liposomes within the tumor microenvironment using multi-spectral optoacoustic tomography (MSOT) [J].
Beziere, Nicolas ;
Lozano, Neus ;
Nunes, Antonio ;
Salichs, Juan ;
Queiros, Daniel ;
Kostarelos, Kostas ;
Ntziachristos, Vasilis .
BIOMATERIALS, 2015, 37 :415-424
[5]   Phase I and pharmacokinetic (PK) study of MAG-CPT (PNU 166148):: a polymeric derivative of camptothecin (CPT) [J].
Bissett, D ;
Cassidy, J ;
de Bono, JS ;
Muirhead, F ;
Main, M ;
Robson, L ;
Fraier, D ;
Magnè, ML ;
Pellizzoni, C ;
Porro, MG ;
Spinelli, R ;
Speed, W ;
Twelves, C .
BRITISH JOURNAL OF CANCER, 2004, 91 (01) :50-55
[6]  
Cabral H, 2011, NAT NANOTECHNOL, V6, P815, DOI [10.1038/nnano.2011.166, 10.1038/NNANO.2011.166]
[7]   Renal clearance of quantum dots [J].
Choi, Hak Soo ;
Liu, Wenhao ;
Misra, Preeti ;
Tanaka, Eiichi ;
Zimmer, John P. ;
Ipe, Binil Itty ;
Bawendi, Moungi G. ;
Frangioni, John V. .
NATURE BIOTECHNOLOGY, 2007, 25 (10) :1165-1170
[8]   New HPMA copolymer-based drug carriers with covalently bound hydrophobic substituents for solid tumour targeting [J].
Chytil, P. ;
Etrych, T. ;
Konak, C. ;
Sirova, M. ;
Mrkvan, T. ;
Boucek, J. ;
Rihova, B. ;
Ulbrich, K. .
JOURNAL OF CONTROLLED RELEASE, 2008, 127 (02) :121-130
[9]   Recent trends in the design of anticancer polymer prodrug nanocarriers [J].
Delplace, Vianney ;
Couvreur, Patrick ;
Nicolas, Julien .
POLYMER CHEMISTRY, 2014, 5 (05) :1529-1544
[10]   Polymer conjugates as anticancer nanomedicines [J].
Duncan, Ruth .
NATURE REVIEWS CANCER, 2006, 6 (09) :688-701